We are a committed group of professionals. Each highly-experienced individual was specially chosen to fit their role.

Our set of skills combined and on-going support from our parent company (CDC Group) allows us to move quickly, efficiently and effectively.

Meet the team

Michael Anderson CB

Chief Executive Officer & Board Member

Michael brings over 30 years’ experience to his leadership role, covering business, government, law, academia and non-profits with a focus on international development.

Before joining MedAccess, Michael was CEO of the Children’s Investment Fund Foundation, having previously served as Director General at DFID, Special Envoy for the UK Prime Minister on International Development, and on the UN Commission for Life-Saving Commodities.  


Elizabeth Arthur

Policy & Operations Associate

Elizabeth provides wide-ranging support on policy, development impact and communication. Her experience comes from a variety of roles in finance (trust and investment), non-profit (African legal & health) and the UK public sector.

Elizabeth holds an MA in International Development, Globalisation and Business from the Institute of Development Studies (IDS).

Colleen Connell

Chief Markets Officer

Colleen leads on identifying, developing, and prioritising financial guarantee opportunities, as well as assessing health markets, technical suitability, and developmental impact. Once a guarantee is agreed, she also manages deal monitoring and implementation.

Colleen joined MedAccess from the Clinton Health Access Initiative, where her roles included Vice President (Access Programs), Senior Director (New Market Opportunities), and Regional Director (Latin America & Caribbean).

Natasha Davie

Health Markets Associate

Natasha analyses health markets to identify financial guarantee opportunities. She also contributes to due diligence, guarantee implementation, and development impact assessment.

Natasha is an engineer by training and holds a PhD in Medical Sciences from the University of Oxford. Prior to joining MedAccess she worked at the Boston Consulting Group for three years as a core member of the healthcare practice area.

Sophie Denman

Executive Assistant

Sophie manages all aspects of team administration for MedAccess, including scheduling, events and communication.

After graduating from the University of Southampton with a BA in Social Anthropology, Sophie worked in high-level assistant roles in NGOs, travel, IT and telecoms companies before joining MedAccess.

Jonathan Hutchins

General Counsel & Chief Operations Officer

Jonathan leads delivery of the price ceiling guarantee product itself. He manages all transactions, oversees the corporate structure, ensures operations are aligned with key objectives and advises on all legal risks.

Jonathan began his career at Clifford Chance, moving on to COO and GC roles at Globeleq, Actis Energy Fund and the Nigeria Sovereign Investment Authority. Prior to joining MedAccess, he worked as Legal Consultant for IFC InfraVentures.

Rivha Kamara

Investment Associate

Rivha supports the work throughout MedAccess from deal origination to the execution and monitoring of transactions both financially and for development impact. Her work includes research and analysis, data collection, due diligence, and portfolio management.

Rivha’s background is in Investments across Investment Banking and Development Finance. Before joining MedAccess, she worked for a development finance institution as an associate covering investments within the chemical products and pharmaceuticals sector.

Evans Mburu

Implementation Executive

Evans collects field data vital to our monitoring of product introduction. In doing so, he gives us broad contextual understanding of how well we’re working towards our objectives.

Evans’ background is in public health and international development. He spent six years working in public health consulting across Africa, mainly in pharmaceutical supply chains, donor-funded health management programmes and financial monitoring. Before joining MedAccess, he worked at KPMG’s International Development Advisory Services.

Simon Sweet

Company Secretary

Simon is Secretary to the Board of Directors and its Committees and oversees corporate governance within the business.

Simon has over 30 years’ experience in senior governance roles in listed and international groups of companies, most recently as Group Company Secretary at Globeleq. He is a Fellow of the Institute of Chartered Secretaries and Administrators.

Michelle Teo

Chief Investment Officer

Michelle manages MedAccess’ guarantee portfolio, through the development of short-term and long-term investment plans, investment analysis, and the monitoring and management of investments.

Before joining MedAccess, Michelle was a Managing Director at Bank of America Merrill Lynch. Her career first began in the field of medicine, after graduating from the University of Oxford with a BA in Physiological Sciences and a BM, BCh.

The Board

Led by Nigel Keen as Chairman, the committee is responsible
for the oversight and governance of MedAccess.

Nigel Keen

Board Chairman

Nigel brings decades of experience in healthcare and commerce to the oversight and governance of MedAccess. His career has encompassed venture capital, industry and banking, and he has been involved in the formation and development of high technology businesses for more than 30 years.

He is currently Chairman of Syncona Investment Management, Oxford Academic Health Science Network and Oxford University Innovation. He also Chairs the AIM-listed medical device company Deltex Medical Group.

Clive MacTavish

Board Member

Clive is the Chief Financial Officer, as well as a Board Member, at CDC Group. He brings to MedAccess extensive global and regional Board-level experience across the e-commerce sectors.

He previously worked as CFO of Expedia’s Global Lodging Group, Finance Director EMEA for Dow Jones and Head of Strategy, Global Financial Controller and Finance Director EMEA at the Financial Times. Clive started his career with PwC as a qualified accountant (ACA).

Diana Noble CBE

Board Member

Diana brings over 30 years’ experience in private equity, venture capital and international development. She combines Board responsibilities with chairing the MedAccess Investment Committee.

Diana has held roles of CEO at CDC Group, Executive Vice President Operations at the Clinton Health Access Initiative and Partner at Schroder Ventures (now Permira). 

Dr. Egbe Osifo-Dawodu

Board Member

Egbe is a Partner at the Anadach Group, providing advisory services to a wide range of clients. She is a member of the UK Royal College of Physicians, with over 30 years’ healthcare experience covering policy, provision and financing in Africa, Asia, Europe, and Latin America.

Egbe has held various positions at the World Bank Group, working on public policy and investment transactions at the International Financial Corporation.

Holger Rothenbusch

Board Member

Holger is Managing Director of the Debt team at CDC Group. He has spent over 20 years in development finance in Latin America, Africa, Asia and Eastern Europe, working across numerous emerging markets, sectors and products.

Prior to joining CDC, Holger held several senior positions at the German Development Finance Institution, including building the Equity & Mezzanine Team. He started his career as a commercial banker with Deutsche Bank.

Willem Verhoofstad

Board Member

Willem is Senior Vice President at Roche Pharma in Switzerland.

He has over 34 years of experience in the pharmaceutical industry, culminating in various global leadership roles in product development, business development, strategic marketing, R&D strategy and portfolio management. His broad and deep experience covers a wide range of therapeutic areas and geographies.